Abivax's IPO

Abivax raised a round of funding on June 05, 2015. Investors include Public.

Abivax is a biotechnology company focused on becoming a global leader in the discovery, development and commercialization of anti-viral compounds and human vaccines to treat some of the world's most i…

Articles about Abivax's IPO: